Our analysis showing decreased detection of neuronal Bin1 in the brains of human Tau P301S expressing mice replicates what has been observed in post-mortem brain samples of AD-affected individuals[20],[21], and validate PS19 as a suitable in vivo model to understand the contribution of BIN1 to AD-like neuropathology. The gene discussed is MAPT; the disease is Alzheimer disease.